The global tetanus toxoid vaccine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Tetanus (popularly known by the name as lockjaw disease) is a non-communicable severe disease which is caused by a bacterial toxin primarily affecting the nervous system. The disease leads to aching muscle contractions, specifically the jaw and neck muscles with symptoms such as paralysis of the jaw, back pain, muscle stiffness, spasms, and difficulties in breathing. The bacterial (Clostridium tetani or the C. tetani) career include soil, human and animal stools, and street dust. The enteral mode of bacteria in the body occurs through wounds. Thus, the growing cases of injuries among people is a key factor that propels the growth of this vaccine usage among the population as a part of preventative care.
To Request a Sample of our Report on Tetanus Toxoid Vaccine Market: https://www.omrglobal.com/request-sample/tetanus-toxoid-vaccine-market
Most cases of tetanus occur in people who have never been vaccinated or in adults who have not kept up with their 10-year booster shots. There are different vaccines that provide protection against tetanus include DTaP vaccine, DT vaccine, Tdap vaccine, and Td vaccine. Rising cases of tetanus and diphtheria, new products under the clinical trials, and increasing government initiatives regarding vaccination and immunization are the key driving factors of the global tetanus toxoid vaccine market. According to the World Health Organization (WHO), in 2015, about 34,000 newborns died from neonatal tetanus all over the globe. In addition, there were 15,103 reported cases of tetanus and diphtheria were reported in 2018, with an increase from 13,500 tetanus cases in 2016. Since the number of cases have increased in the past few years, the market is likely to grow in the future years.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: GlaxoSmithKline plc, Merck & Co., Inc., and Sanofi S.A., among others.
(Get 15% Discount on Buying this Report)
A full Report of Tetanus Toxoid Vaccine Market is Available @ https://www.omrglobal.com/industry-reports/tetanus-toxoid-vaccine-market
Global Tetanus Toxoid Vaccine Market Report by Segment
By Type
- Diphtheria, Tetanus, and Pertussis (DTaP)
- Diphtheria and Tetanus (DT)
- Tetanus, Diphtheria, and Pertussis (Tdap)
- Others
By Application
- Hospitals and Clinics
- Government Organizations
Global Tetanus Toxoid Vaccine Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
